Clinical Trials
8 trialsNCT07086768 2026-06-03
Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors
The University of Texas Health Science Center at San Antonio
Phase 1 Recruiting
NCT06486883 2026-06-02
PONTIAC
MedSIR
Phase 2 Recruiting
NCT07619365 2026-06-02
Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer
Washington University School of Medicine
Phase 2 Not yet recruiting
NCT06551220 2026-05-22
HEROIC
Sun Yat-sen University
Recruiting
NCT06663787 2026-05-13
HER2 CR
Nagoya City University
Active not recruiting
NCT07582887 2026-05-13
Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Recruiting
NCT06048718 2026-05-08
TUXEDO-4
MedSIR
Phase 2 Active not recruiting
NCT06750484 2026-05-06
Trial of Trastuzumab Deruxtecan in Previously Treated HER2
Yale University
Phase 2 Recruiting